CH7450924, a KEAP1-NRF2 interaction inhibitor, ameliorates LPS-induced multiple organ dysfunction via inflammatory pathway inhibition.

Although the reduction of TNFα mRNA in the liver did not reach statistical significance, a clear downward trend was observed following CH7450924 administration (Fig. 2 C, D).

also in 111,027 other papers